MDxHealth S.A. cash flow to debt ratio of -10.95% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

MDxHealth S.A.'s free cash flow has increased -44.06% from $-20.69M last year to $-11.57M, signaling increasing performance

MDxHealth S.A.'s debt to equity ratio is -7.86, signaling that the company spent its equity and risk bankruptcy.

MDxHealth S.A.'s debt to equity ratio is -7.86, signaling that the company spent its equity and risk bankruptcy.

MDxHealth S.A. has negative EBITDA, making leverage ratio unreliable

MDxHealth S.A.'s interest coverage ratio is -0.92, which means that the company struggles to meet interest obligations, signaling financial risk.

MDxHealth S.A.'s profit margin has increased (-23.90%) in the last year from -42.28% to -32.17%, signaling increasing performance

MDxHealth S.A.'s short-term assets of $53.41M exceed its short-term liabilities of $49.53M

MDxHealth S.A.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

MDxHealth S.A.'s return on equity of 402.97%, is higher than 15.00%, indicating good performance

MDxHealth S.A.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

MDxHealth S.A. has insufficient public price history to evaluate earnings stability.

MDxHealth S.A. has negative free cash flow, indicating the company is burning cash rather than generating it

MDxHealth S.A. has negative free cash flow, indicating cash burn

MDxHealth S.A.'s yearly earnings has increased -11.95% since last year from $-38.07M to $-33.52M, signaling increasing performance

MDxHealth S.A.'s yearly revenue has increased 19.80% since last year from $90.05M to $107.88M, signaling increasing performance

ROIC -12.74% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

MDxHealth S.A.'s 3-year revenue CAGR of 42.79% is positive, indicating growing revenue over the past 3 years

MDxHealth S.A. had revenue growth in 5 out of 5 years, indicating consistent revenue performance

MDxHealth S.A. has insufficient public price history to evaluate ROE consistency.

MDxHealth S.A. has insufficient data to evaluate this check.

MDxHealth S.A. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

MDxHealth S.A. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

MDxHealth S.A. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

MDxHealth S.A. has insufficient data to evaluate this check.

MDxHealth S.A. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

MDxHealth S.A. has negative shareholder equity; price-to-book is not meaningful and the check fails

MDxHealth S.A. has a price-to-sales ratio of 0.28x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue